The Data Safety Monitoring Board (DSMB) identified no safety concerns, and recommended continuation of BriaCell’s pivotal Phase 3 study of Bria-IMT™ plus immune check point inhibitor in ...

Belite Bio, Inc. announced that the independent Data Safety Monitoring Board (DSMB) recommended the continuation of the Phase 3 DRAGON trial for Tinlarebant, an experimental treatment for ...

The DEEp SEA Study (LP352-302) is a global Phase 3 double-blind, placebo-controlled clinical trial to evaluate the efficacy of bexicaserin in Dravet syndrome as assessed by countable motor ...